EP2854841
Kallikrein-1 glýkósýleringarísóform úr mennskum vef
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
4.6.2013EP published:
22.2.2017EP application number:
13801165.5
EP translation filed:
3.5.2017Grant published:
15.5.2017EPO information:
European Patent Register
Max expiry date:
3.6.2033Expiry date:
3.6.2019
Title:
HUMAN TISSUE KALLIKREIN 1 GLYCOSYLATION ISOFORMS
Timeline
Today
4.6.2013EP application
22.2.2017EP Publication
3.5.2017Translation submitted
15.5.2017Registration published
3.6.2019Expires
Owner
Name:
DiaMedica Therapeutics Inc.Address:
301 – 1665 Ellis Street, V1Y 2B3, Kelowna BC, CA
Inventor
Name:
CHARLES, MatthewAddress:
St. Louis Park, Minnesota, US
Name:
KOLODKA, TadeuszAddress:
Plymouth, Minnesota, US
Name:
WILLIAMS, MarkAddress:
Plymouth, Minnesota, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261655388 PDate:
4.6.2012Country:
US
Number:
201361789978 PDate:
15.3.2013Country:
US
Classification
Categories:
A61K 38/48, A61P 3/10
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 30.6.2017
Expires: 3.6.2018
Payer: Árnason Faktor
Number: 6
Paid: 6.7.2018
Expires: 3.6.2019
Payer: Árnason Faktor